(1)
Gordon, K. B.; Langley, R. G.; Warren, R. B.; Okubo, Y.; Rosmarin, D.; Lebwohl, M.; Peterson, L.; Madden, C.; de Cuyper, D.; Gomez, N. N.; Thaçi, D. Bimekizumab Safety in Patients With Moderate to Severe Plaque Psoriasis: Analysis of Pooled Data from up to Three Years of Treatment in Phase 2 and 3 Clinical Trials. J of Skin 2022, 6, s66.